Metronidazole in a single dose for the treatment of trichomoniasis. Failure of a 1-g single dose.
AUTOR(ES)
Austin, T W
RESUMO
To determine the minimum effective dose of metronidazole in the treatment of vaginal trichomoniasis, a randomised clinical trial comparing single 1-g and 2-g doses was carried out on 163 patients attending sexually transmitted diseases and family planning clinics. Seventy-two of 86 (84%) patients receiving a single 2-g dose of metronidazole were cured compared with only 42 of 77 (55%) receiving a 1-g dose. The body weight of the patient was a significant variable affecting treatment outcome only in the latter group; 69% of patients weighing more than 57 kg or less when cured compared with only 43% of those weighing more. Patients who failed after either dose regimen were retreated with a single 2-g dose. Eighteen of 21 (86%) and seven of 10 (70%) failures with the initial 1-g and 2-g doses respectively were cured. A single 1-g dose of metronidazole is not recommended as routine treatment for vaginal trichomoniasis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1046021Documentos Relacionados
- Double-blind comparison of a single dose and a five-day course of metronidazole in the treatment of trichomoniasis.
- Two-day treatment with metronidazole in vaginal trichomoniasis.
- Metronidazole in the single-dose treatment of trichomoniasis in men and women.
- Treatment of uncomplicated gonorrhoea in women with talampicillin in a single oral 1.5 g dose.
- Nitrimidazine in the treatment of trichomoniasis.
